Alfresa's operating profit FY 2013-2018
In the fiscal year 2018, the operating income of Alfresa Holdings Corporation amounted to approximately 44.7 billion Japanese yen, up from around 34.9 billion Japanese yen in fiscal year 2013. The main businesses of the Japanese pharmaceutical company include ethical pharmaceutical wholesaling, self-medication products wholesaling, manufacturing, and the medical-related business.